CVS HEALTH
CVS HEALTH reported 21 stocks worth $225M in its 13F filing for Q2 2026, filed Aug 6, 2026. Its largest holdings are IGSB (20.7%), IGIB (10.4%) and IEI (9.5%). Compared with Q1 2026, the fund opened new positions in LQD, HYG and DRAM, added to IGSB, IGIB and SHY, trimmed RSP and sold out of SPY, XLV and VEA.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  IGSB Ishares TR | $46.6M | 20.7% | 890K | +596K (+202%) | 3 of 8 | |
| 2 |  IGIB Ishares TR | $23.4M | 10.4% | 440K | +347K (+374%) | 3 of 8 | |
| 3 |  IEI Ishares TR | $21.5M | 9.5% | 183K | No change | 2 of 8 | |
| 4 |  SHY Ishares 1-3 Year Treasry | $21.2M | 9.4% | 258K | +25K (+11%) | 2 of 8 | |
| 5 |  USHY Ishares TR | $17.7M | 7.9% | 478K | +130K (+37%) | 3 of 8 | |
| 6 |  EMB Ishares TR | $17.4M | 7.7% | 180K | +73K (+68%) | 2 of 8 | |
| 7 |  AGG Ishares TR | $14.8M | 6.6% | 150K | No change | 2 of 8 | |
| 8 |  VCSH Vanguard Scottsdale Fds | $9.5M | 4.2% | 120K | No change | 2 of 8 | |
| 9 |  IGLB Ishares TR | $8.8M | 3.9% | 175K | +75K (+75%) | 2 of 8 | |
| 10 |  LQD Ishares Iboxx Invt Grade | $7.6M | 3.4% | 70K | New position | 1 of 8 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
 SPY Spdr S&P 500 ETF TR | $57M | 88K |
 XLV State Street | $1.8M | 12K |
 VEA Vanguard Tax-Managed Fds | $1.3M | 20K |
 XLU Select Sector Spdr TR | $1.1M | 25K |
 IEMG Ishares Inc | $1M | 15K |
🔒 Free account: see all 16.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 6, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →CVS HEALTH 13F FAQ
What does CVS HEALTH own?
CVS HEALTH reported 21 stocks worth $225M in its 13F filing for Q2 2026, filed Aug 6, 2026. Its largest holdings are IGSB (20.7%), IGIB (10.4%) and IEI (9.5%). The table above lists every position in the filing (the top 10 without an account).
What did CVS HEALTH buy and sell in Q2 2026?
Compared with Q1 2026: 4 new positions, 7 added to, 1 trimmed and 16 sold out. New positions include LQD, HYG and DRAM. It sold all of SPY, XLV and VEA.
When will CVS HEALTH file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is CVS HEALTH's portfolio worth?
The Q2 2026 filing reports $225M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.